Low-dose natural human interferon-alpha lozenges in the treatment of Behçet's syndrome.

Rheumatology (Oxford, England)

Volumn 48, Issue 11, 2009, Pages 1388-1391

  Kiliç, Hasan ^a   Zeytin, Hasan E ^a   Korkmaz, Cengiz ^a   Mat, Cem ^a   Gül, Ahmet ^a   Coşan, Fulya ^a   Dinç, Ayhan ^a   Simşek, Ismail ^a   Süt, Necdet ^a   Yazici, Hasan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; BEHCET DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MOUTH ULCER; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TABLET; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; BEHCET SYNDROME; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; ORAL ULCER; TABLETS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 73349125080     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep237     Document Type: Article

References (0)